Home > PS Ratio > JUBILANT PHARMOVA

JUBILANT PHARMOVA
PS (Price/Sales) Ratio

The Current P/S Ratio of JUBILANT PHARMOVA is 2.35.

Share Price ₹1,125.9Nov 13,2025
Market Cap ₹17,934.8 Cr
Sales-TTM₹7,617.6 CrTTM-Consolidated Results
Price/Sales2.35xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results
JUBILANT PHARMOVA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of JUBILANT PHARMOVA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of JUBILANT PHARMOVA is calculated as :

Current Market Cap [ ₹17,934.8 Cr] as on Nov 13,2025

(/) Sales [ ₹7,617.6 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.35x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for JUBILANT PHARMOVA , the investors are currently willing to pay '2.35 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of JUBILANT PHARMOVA !

The chart below summarizes the trend in P/S Ratio of JUBILANT PHARMOVA over the last five years.

Historical PS (Price/Sales) ratio chart of JUBILANT PHARMOVA


PS Ratio Performance Analysis for JUBILANT PHARMOVA

- JUBILANT PHARMOVA 's latest p/e ratio is 2.35x.

- JUBILANT PHARMOVA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.36x.

- JUBILANT PHARMOVA 's operated at median p/e ratio of 1.34x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JUBILANT PHARMOVA 's p/e ratio peaked in Mar2025 at 1.95x.

- JUBILANT PHARMOVA 's p/e ratio hit its five-year low in Mar2023 of 0.71x.


How does JUBILANT PHARMOVA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
JUBILANT PHARMOVA 7,617.62.3517,934.8
SUN PHARMACEUTICAL INDUSTRIES LTD54,964.07.58416,477.0
DIVIS LABORATORIES LTD10,029.017.44174,934.0
CIPLA LTD28,349.64.35123,250.0
TORRENT PHARMACEUTICALS LTD12,248.010.57129,469.0
DR REDDYS LABORATORIES LTD34,310.03.00103,038.0
MANKIND PHARMA LTD13,576.96.8693,120.4
ZYDUS LIFESCIENCES LTD24,493.93.8895,008.6
LUPIN LTD24,750.73.7993,768.7
AUROBINDO PHARMA LTD32,514.52.1670,210.2
ABBOTT INDIA LTD6,714.49.3562,801.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JUBILANT PHARMOVA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.16x
Max industry PS 17.44x
Median industry PS 4.35x
Average industry PS 6.48x



You may also like the below Video Courses